Company intelligence / Profile preview

Glofinn America

Boca Raton, Florida, United States

Ownership: Private
Development stage: Other

Overview

Glofinn America is a medical technology company specializing in regenerative medicine, specifically Platelet-Rich Plasma (PRP) therapy. The company provides the GloPRP system, a patented technology designed for the efficient concentration of platelets and growth factors from a patient's own blood. Their products are utilized across various clinical fields, including orthopedics, sports medicine, aesthetics, and wound care. Glofinn America focuses on delivering high-concentration PRP solutions to enhance natural healing processes and tissue regeneration. The system is designed for ease of use in clinical settings, allowing for rapid processing of autologous blood samples to support biological therapy.

Therapeutic areas: RheumatologyDermatologyOther
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Glofinn America.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glofinn America.

Explore the full profile